XML 23 R35.htm IDEA: XBRL DOCUMENT v3.20.1
Share Based Compensation (Tables)
3 Months Ended
Mar. 31, 2020
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions The assumptions used to value SARs granted during 2019 were as follows:
 
5-year vesting SARs
7-year vesting SARs
Risk-free interest rate
2.43
%
2.51
%
Expected dividend yield
2.30
%
2.30
%
Expected common stock volatility
35.71
%
40.84
%
Expected life
6.5 years

7.0 years


Schedule of Share-based Compensation, Stock Options, Activity
A summary of our SAR and stock option activity the first three months of 2020 and 2019 is as follows:
 
For the Three Months Ended March 31,
 
2020
 
Options/SARs
 
Aggregate
Intrinsic
Value (in thousands)
 
Remaining
Contractual
Term (Yrs.)
 
Weighted-Average
Exercise Price
Outstanding, January 1
330,703

 
 
 
 
 
$
20.44

Granted

 
 
 
 
 

Exercised

 
 
 
 
 

Forfeited

 
 
 
 
 

Expired

 
 
 
 
 

Outstanding, March 31
330,703

 
$
1,039

 
7.08
 
$
20.44

 
 
 
 
 
 
 
 
Exercisable, March 31
146,031

 
$
732

 
6.24
 
$
18.18


 
For the Three Months Ended March 31,
 
2019
 
Options/SARs
 
Aggregate
Intrinsic
Value
(in thousands)
 
Remaining
Contractual
Term (Yrs.)
 
Weighted-Average
Exercise Price
Outstanding, January 1
232,091

 
 
 
 
 
$
17.36

Granted
138,125

 
 
 
 
 
23.94

Exercised

 
 
 
 
 

Forfeited

 
 
 
 
 

Expired

 
 
 
 
 

Outstanding, March 31
370,216

 
$
2,478

 
7.83
 
$
19.82

 
 
 
 
 
 
 
 
Exercisable, March 31
111,058

 
$
1,129

 
6.16
 
$
15.77



Schedule of Share-based Compensation, Restricted Stock Units Award Activity A summary of our RSU activity and related information is as follows.
Dollars in thousands, except per share amounts
RSUs
 
Weighted Average Grant Date Fair Value
Nonvested, December 31, 2019
2,892

 
25.93

Granted
1,846

 
27.09

Exercised

 

Forfeited

 

Vested

 

Nonvested, March 31, 2020
4,738

 
26.38